UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.735-737

2016

Volltextzugriff (PDF)

Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients

Leukemia & lymphoma, 2018-11, Vol.59 (11), p.2734-2736

2018

Volltextzugriff (PDF)

The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1644-1649

2019

Volltextzugriff (PDF)

Intracerebral immunotherapy for brain tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13522-e13522

2019

Volltextzugriff (PDF)

A Simple Score, Based on Geriatric Assessment, Predicts Survival in Elderly Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Blood, 2016-12, Vol.128 (22), p.2036-2036

2016

Volltextzugriff (PDF)

Is the International Prognostic INDEX for CLL (CLL-IPI) Useful to Predict Time to First Treatment of Patients with EARLY Disease? Results of a Prospective Multicenter Analysis

Blood, 2015-12, Vol.126 (23), p.498-498

2015

Volltextzugriff (PDF)

Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?

Advances in Hematology, 2009, Vol.2009 (2009), p.55-60

2009

Volltextzugriff (PDF)

Exclusion of SERUM Thymidine Kinase Does NOT Reduce the Predictive VALUE of a Comprehensive Prognostic INDEX in Chonic Lymphocytic Leukemia. Results of an External Validation on a Prospective Cohort of Patients with EARLY Disease

Blood, 2014-12, Vol.124 (21), p.4692-4692

2014

Volltextzugriff (PDF)

Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines

Expert review of hematology, 2014-10, Vol.7 (5), p.691-695

2014

Volltextzugriff (PDF)

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Blood, 2011-11, Vol.118 (21), p.4601-4601

2011

Volltextzugriff (PDF)

Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients

Leukemia & lymphoma, 2006-11, Vol.47 (11), p.2421-2423

2006

Volltextzugriff (PDF)

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Blood, 2008-11, Vol.112 (11), p.4158-4158

2008

Volltextzugriff (PDF)

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Blood, 2008-11, Vol.112 (11), p.4187-4187

2008

Volltextzugriff (PDF)

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia

Blood, 2007-11, Vol.110 (11), p.3093-3093

2007

Volltextzugriff (PDF)

Characteristics and Outcome of B-Cell Chronic Lymphocytic Leukemia in HCV-Positive Patients

Blood, 2005-11, Vol.106 (11), p.4986-4986

2005

Volltextzugriff (PDF)

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia

Blood, 2006-11, Vol.108 (11), p.2786-2786

2006

Volltextzugriff (PDF)

Efficacy and Safety of a First Line Combined Therapeutic Approach for Young CLL Patients with Advanced or Progressive Disease Stratified According to the Biologic Features: First Analysis of the GIMEMA Multicenter Study LLC0405

Blood, 2010-11, Vol.116 (21), p.2471-2471

2010

Volltextzugriff (PDF)

Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia

Blood, 2006-11, Vol.108 (11), p.4985-4985

2006

Volltextzugriff (PDF)

Serum Insulinlike Growth Factor Is Not Elevated in Patients with Early B-Cell Chronic Lymphocytic Leukemia but Is Still a Prognostic Factor for Disease-Progression

Blood, 2004-11, Vol.104 (11), p.4786-4786

2004

Volltextzugriff (PDF)

Angiogenesis in Chronic Lymphocytic Leukemia: An Emerging Target

Clinical leukemia, 2006-12, Vol.1 (2), p.118-122

2006

Volltextzugriff (PDF)

Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients

Leukemia & lymphoma, 2018, Vol.59 (11), p.2734-2736

2018

Volltextzugriff (PDF)

Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs

Journal of the American Chemical Society, 2019-07, Vol.141 (30), p.12109-12120

2019

Volltextzugriff (PDF)

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.5213-5213

2018

Volltextzugriff (PDF)

Role of Niemann-Pick Type C Disease Mutations in Dementia

Journal of Alzheimer's disease, 2017-01, Vol.55 (3), p.1249-1259

2017

Volltextzugriff (PDF)

Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia

Journal of Alzheimer's disease, 2018-01, Vol.61 (3), p.1179-1187

2018

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(11)
Male
(11)
Middle Aged
(11)
Female
(10)
Aged
(8)
Neurosciences
(7)
Neurosciences & Neurology
(7)
Mutation - Genetics
(6)
Hematology
(5)
Adult
(4)
Aged, 80 And Over
(4)
Alzheimer Disease - Genetics
(4)
Oncology
(4)
Alzheimer's Disease
(3)
Dementia
(3)
Family Health
(3)
Italy
(3)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(13)
Journal Of Alzheimer's Disease
(8)
Leukemia & Lymphoma
(4)
Advances In Hematology
(1)
Clinical Leukemia
(1)
Expert Review Of Hematology
(1)
Journal Of Clinical Oncology
(1)
Journal Of The American Chemical Society
(1)
Neurobiology Of Aging
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature

Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients

The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis

Intracerebral immunotherapy for brain tumors

A Simple Score, Based on Geriatric Assessment, Predicts Survival in Elderly Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Is the International Prognostic INDEX for CLL (CLL-IPI) Useful to Predict Time to First Treatment of Patients with EARLY Disease? Results of a Prospective Multicenter Analysis

Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?

Exclusion of SERUM Thymidine Kinase Does NOT Reduce the Predictive VALUE of a Comprehensive Prognostic INDEX in Chonic Lymphocytic Leukemia. Results of an External Validation on a Prospective Cohort of Patients with EARLY Disease

Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia

Characteristics and Outcome of B-Cell Chronic Lymphocytic Leukemia in HCV-Positive Patients

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia

Efficacy and Safety of a First Line Combined Therapeutic Approach for Young CLL Patients with Advanced or Progressive Disease Stratified According to the Biologic Features: First Analysis of the GIMEMA Multicenter Study LLC0405

Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia

Serum Insulinlike Growth Factor Is Not Elevated in Patients with Early B-Cell Chronic Lymphocytic Leukemia but Is Still a Prognostic Factor for Disease-Progression

Angiogenesis in Chronic Lymphocytic Leukemia: An Emerging Target

Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients

Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Role of Niemann-Pick Type C Disease Mutations in Dementia

Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia

Aktive Filter

Suchergebnisse filtern